CN104188036A - Formula of plant beverage - Google Patents
Formula of plant beverage Download PDFInfo
- Publication number
- CN104188036A CN104188036A CN201410486537.3A CN201410486537A CN104188036A CN 104188036 A CN104188036 A CN 104188036A CN 201410486537 A CN201410486537 A CN 201410486537A CN 104188036 A CN104188036 A CN 104188036A
- Authority
- CN
- China
- Prior art keywords
- formula
- people
- food
- chinese
- effect
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 235000013361 beverage Nutrition 0.000 title claims abstract description 9
- 235000013305 food Nutrition 0.000 claims abstract description 24
- 235000009917 Crataegus X brevipes Nutrition 0.000 claims abstract description 15
- 235000013204 Crataegus X haemacarpa Nutrition 0.000 claims abstract description 15
- 235000009685 Crataegus X maligna Nutrition 0.000 claims abstract description 15
- 235000009444 Crataegus X rubrocarnea Nutrition 0.000 claims abstract description 15
- 235000009486 Crataegus bullatus Nutrition 0.000 claims abstract description 15
- 235000017181 Crataegus chrysocarpa Nutrition 0.000 claims abstract description 15
- 235000009682 Crataegus limnophila Nutrition 0.000 claims abstract description 15
- 235000004423 Crataegus monogyna Nutrition 0.000 claims abstract description 15
- 235000002313 Crataegus paludosa Nutrition 0.000 claims abstract description 15
- 235000009840 Crataegus x incaedua Nutrition 0.000 claims abstract description 15
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 13
- 235000002722 Dioscorea batatas Nutrition 0.000 claims abstract description 12
- 235000006536 Dioscorea esculenta Nutrition 0.000 claims abstract description 12
- 240000001811 Dioscorea oppositifolia Species 0.000 claims abstract description 12
- 235000003416 Dioscorea oppositifolia Nutrition 0.000 claims abstract description 12
- 235000021552 granulated sugar Nutrition 0.000 claims abstract description 4
- 230000001954 sterilising effect Effects 0.000 claims abstract description 4
- 238000004659 sterilization and disinfection Methods 0.000 claims abstract description 4
- 241000196324 Embryophyta Species 0.000 claims abstract description 3
- 240000000171 Crataegus monogyna Species 0.000 claims abstract 2
- 239000003814 drug Substances 0.000 claims description 21
- 239000003795 chemical substances by application Substances 0.000 claims description 20
- 244000037364 Cinnamomum aromaticum Species 0.000 claims description 19
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 claims description 19
- 238000004040 coloring Methods 0.000 claims description 16
- 244000241872 Lycium chinense Species 0.000 claims description 8
- 235000015468 Lycium chinense Nutrition 0.000 claims description 8
- 235000013399 edible fruits Nutrition 0.000 claims description 8
- 244000046146 Pueraria lobata Species 0.000 claims description 7
- 235000010575 Pueraria lobata Nutrition 0.000 claims description 7
- 238000000034 method Methods 0.000 claims description 6
- 239000000203 mixture Substances 0.000 claims description 4
- 239000002245 particle Substances 0.000 claims description 3
- 230000000694 effects Effects 0.000 abstract description 35
- 239000008280 blood Substances 0.000 abstract description 14
- 210000004369 blood Anatomy 0.000 abstract description 13
- 210000004185 liver Anatomy 0.000 abstract description 12
- 230000036541 health Effects 0.000 abstract description 8
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 7
- 201000010099 disease Diseases 0.000 abstract description 6
- 238000010521 absorption reaction Methods 0.000 abstract description 4
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 abstract description 3
- 206010020772 Hypertension Diseases 0.000 abstract description 3
- 240000007594 Oryza sativa Species 0.000 abstract description 3
- 235000007164 Oryza sativa Nutrition 0.000 abstract description 3
- 239000011575 calcium Substances 0.000 abstract description 3
- 229910052791 calcium Inorganic materials 0.000 abstract description 3
- 208000026106 cerebrovascular disease Diseases 0.000 abstract description 3
- 230000003014 reinforcing effect Effects 0.000 abstract description 3
- 235000007189 Oryza longistaminata Nutrition 0.000 abstract description 2
- 230000003111 delayed effect Effects 0.000 abstract description 2
- 210000000582 semen Anatomy 0.000 abstract description 2
- 239000003053 toxin Substances 0.000 abstract description 2
- 231100000765 toxin Toxicity 0.000 abstract description 2
- 208000031226 Hyperlipidaemia Diseases 0.000 abstract 2
- 201000001421 hyperglycemia Diseases 0.000 abstract 2
- 208000008589 Obesity Diseases 0.000 abstract 1
- 235000006545 Ziziphus mauritiana Nutrition 0.000 abstract 1
- 244000126002 Ziziphus vulgaris Species 0.000 abstract 1
- 235000008529 Ziziphus vulgaris Nutrition 0.000 abstract 1
- 230000002490 cerebral effect Effects 0.000 abstract 1
- 206010008118 cerebral infarction Diseases 0.000 abstract 1
- 238000007872 degassing Methods 0.000 abstract 1
- 238000005538 encapsulation Methods 0.000 abstract 1
- 238000001914 filtration Methods 0.000 abstract 1
- 208000010125 myocardial infarction Diseases 0.000 abstract 1
- 235000020824 obesity Nutrition 0.000 abstract 1
- 206010036067 polydipsia Diseases 0.000 abstract 1
- 238000002791 soaking Methods 0.000 abstract 1
- 241001092040 Crataegus Species 0.000 description 13
- 241000699666 Mus <mouse, genus> Species 0.000 description 9
- 239000000284 extract Substances 0.000 description 9
- 230000006870 function Effects 0.000 description 9
- 210000000952 spleen Anatomy 0.000 description 9
- 210000002784 stomach Anatomy 0.000 description 9
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 8
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 7
- 239000007788 liquid Substances 0.000 description 7
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 6
- LQGUBLBATBMXHT-UHFFFAOYSA-N chrysophanol Chemical compound C1=CC=C2C(=O)C3=CC(C)=CC(O)=C3C(=O)C2=C1O LQGUBLBATBMXHT-UHFFFAOYSA-N 0.000 description 6
- 230000002401 inhibitory effect Effects 0.000 description 6
- ZOOGRGPOEVQQDX-UUOKFMHZSA-N 3',5'-cyclic GMP Chemical compound C([C@H]1O2)OP(O)(=O)O[C@H]1[C@@H](O)[C@@H]2N1C(N=C(NC2=O)N)=C2N=C1 ZOOGRGPOEVQQDX-UUOKFMHZSA-N 0.000 description 5
- 241000228347 Monascus <ascomycete fungus> Species 0.000 description 5
- 241000700159 Rattus Species 0.000 description 5
- 244000269722 Thea sinensis Species 0.000 description 5
- 238000002347 injection Methods 0.000 description 5
- 239000007924 injection Substances 0.000 description 5
- 210000003734 kidney Anatomy 0.000 description 5
- 244000201986 Cassia tora Species 0.000 description 4
- 235000014552 Cassia tora Nutrition 0.000 description 4
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 4
- 241000283973 Oryctolagus cuniculus Species 0.000 description 4
- 208000002193 Pain Diseases 0.000 description 4
- 150000001413 amino acids Chemical class 0.000 description 4
- 230000003796 beauty Effects 0.000 description 4
- 229910052742 iron Inorganic materials 0.000 description 4
- 230000036407 pain Effects 0.000 description 4
- 230000035922 thirst Effects 0.000 description 4
- 241000894006 Bacteria Species 0.000 description 3
- 206010012735 Diarrhoea Diseases 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- 230000009471 action Effects 0.000 description 3
- 230000009286 beneficial effect Effects 0.000 description 3
- 210000000988 bone and bone Anatomy 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 230000007812 deficiency Effects 0.000 description 3
- 206010012601 diabetes mellitus Diseases 0.000 description 3
- 235000004879 dioscorea Nutrition 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 230000004438 eyesight Effects 0.000 description 3
- 238000003304 gavage Methods 0.000 description 3
- 230000001077 hypotensive effect Effects 0.000 description 3
- 230000036039 immunity Effects 0.000 description 3
- 150000002632 lipids Chemical class 0.000 description 3
- 210000004072 lung Anatomy 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 230000002107 myocardial effect Effects 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 238000005728 strengthening Methods 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 235000000346 sugar Nutrition 0.000 description 3
- 230000001225 therapeutic effect Effects 0.000 description 3
- 150000003626 triacylglycerols Chemical class 0.000 description 3
- 238000003809 water extraction Methods 0.000 description 3
- 235000014101 wine Nutrition 0.000 description 3
- JLTCWSBVQSZVLT-CDIPANDDSA-N (2s)-n-[(2s)-6-amino-1-[(2-amino-2-oxoethyl)amino]-1-oxohexan-2-yl]-1-[(4r,7s,10s,13s,16s,19r)-19-amino-7-(2-amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-13-benzyl-16-[(4-hydroxyphenyl)methyl]-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosan Chemical compound NCCCC[C@@H](C(=O)NCC(N)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H]1NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC=2C=CC=CC=2)NC(=O)[C@H](CC=2C=CC(O)=CC=2)NC(=O)[C@@H](N)CSSC1.C([C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CSSC[C@@H](C(N[C@@H](CC=2C=CC(O)=CC=2)C(=O)N1)=O)N)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)C1=CC=CC=C1 JLTCWSBVQSZVLT-CDIPANDDSA-N 0.000 description 2
- 108010051913 15-hydroxyprostaglandin dehydrogenase Proteins 0.000 description 2
- 102100030489 15-hydroxyprostaglandin dehydrogenase [NAD(+)] Human genes 0.000 description 2
- 102100028207 6-phosphogluconate dehydrogenase, decarboxylating Human genes 0.000 description 2
- 206010000087 Abdominal pain upper Diseases 0.000 description 2
- YDQWDHRMZQUTBA-UHFFFAOYSA-N Aloe emodin Chemical compound C1=CC=C2C(=O)C3=CC(CO)=CC(O)=C3C(=O)C2=C1O YDQWDHRMZQUTBA-UHFFFAOYSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 241000193830 Bacillus <bacterium> Species 0.000 description 2
- 241000255789 Bombyx mori Species 0.000 description 2
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Chemical compound CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 description 2
- 208000024172 Cardiovascular disease Diseases 0.000 description 2
- 206010011224 Cough Diseases 0.000 description 2
- JPVYNHNXODAKFH-UHFFFAOYSA-N Cu2+ Chemical compound [Cu+2] JPVYNHNXODAKFH-UHFFFAOYSA-N 0.000 description 2
- 101710151348 D-3-phosphoglycerate dehydrogenase Proteins 0.000 description 2
- 206010013935 Dysmenorrhoea Diseases 0.000 description 2
- 208000004930 Fatty Liver Diseases 0.000 description 2
- 229940121710 HMGCoA reductase inhibitor Drugs 0.000 description 2
- 206010019708 Hepatic steatosis Diseases 0.000 description 2
- 208000001953 Hypotension Diseases 0.000 description 2
- 241000699670 Mus sp. Species 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical group CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- 241000893976 Nannizzia gypsea Species 0.000 description 2
- 208000001132 Osteoporosis Diseases 0.000 description 2
- 241000756042 Polygonatum Species 0.000 description 2
- 235000008737 Polygonatum biflorum Nutrition 0.000 description 2
- 208000004880 Polyuria Diseases 0.000 description 2
- 102000005320 Posterior Pituitary Hormones Human genes 0.000 description 2
- 108010070873 Posterior Pituitary Hormones Proteins 0.000 description 2
- 102000019197 Superoxide Dismutase Human genes 0.000 description 2
- 108010012715 Superoxide dismutase Proteins 0.000 description 2
- 208000037386 Typhoid Diseases 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- UCTWMZQNUQWSLP-UHFFFAOYSA-N adrenaline Chemical compound CNCC(O)C1=CC=C(O)C(O)=C1 UCTWMZQNUQWSLP-UHFFFAOYSA-N 0.000 description 2
- 230000008485 antagonism Effects 0.000 description 2
- PYKYMHQGRFAEBM-UHFFFAOYSA-N anthraquinone Natural products CCC(=O)c1c(O)c2C(=O)C3C(C=CC=C3O)C(=O)c2cc1CC(=O)OC PYKYMHQGRFAEBM-UHFFFAOYSA-N 0.000 description 2
- 150000004056 anthraquinones Chemical class 0.000 description 2
- RJGDLRCDCYRQOQ-UHFFFAOYSA-N anthrone Chemical compound C1=CC=C2C(=O)C3=CC=CC=C3CC2=C1 RJGDLRCDCYRQOQ-UHFFFAOYSA-N 0.000 description 2
- 230000003712 anti-aging effect Effects 0.000 description 2
- 230000001093 anti-cancer Effects 0.000 description 2
- 239000006286 aqueous extract Substances 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 235000012000 cholesterol Nutrition 0.000 description 2
- NZPQWZZXRKZCDU-UHFFFAOYSA-N chrysophanol Natural products Cc1cc(O)c2C(=O)c3c(O)cccc3Oc2c1 NZPQWZZXRKZCDU-UHFFFAOYSA-N 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 208000029078 coronary artery disease Diseases 0.000 description 2
- 230000002354 daily effect Effects 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 230000035619 diuresis Effects 0.000 description 2
- 208000001848 dysentery Diseases 0.000 description 2
- 230000002526 effect on cardiovascular system Effects 0.000 description 2
- 201000005577 familial hyperlipidemia Diseases 0.000 description 2
- 208000010706 fatty liver disease Diseases 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 150000004676 glycans Chemical class 0.000 description 2
- 230000023597 hemostasis Effects 0.000 description 2
- 208000006454 hepatitis Diseases 0.000 description 2
- 230000002218 hypoglycaemic effect Effects 0.000 description 2
- 208000021822 hypotensive Diseases 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 210000000936 intestine Anatomy 0.000 description 2
- 238000010253 intravenous injection Methods 0.000 description 2
- CJWQYWQDLBZGPD-UHFFFAOYSA-N isoflavone Natural products C1=C(OC)C(OC)=CC(OC)=C1C1=COC2=C(C=CC(C)(C)O3)C3=C(OC)C=C2C1=O CJWQYWQDLBZGPD-UHFFFAOYSA-N 0.000 description 2
- 235000008696 isoflavones Nutrition 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 235000013372 meat Nutrition 0.000 description 2
- 210000004914 menses Anatomy 0.000 description 2
- 239000000401 methanolic extract Substances 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- 235000010755 mineral Nutrition 0.000 description 2
- 210000004165 myocardium Anatomy 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- FFWOKTFYGVYKIR-UHFFFAOYSA-N physcion Chemical compound C1=C(C)C=C2C(=O)C3=CC(OC)=CC(O)=C3C(=O)C2=C1O FFWOKTFYGVYKIR-UHFFFAOYSA-N 0.000 description 2
- 210000002381 plasma Anatomy 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- 235000015277 pork Nutrition 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 230000001543 purgative effect Effects 0.000 description 2
- 238000010791 quenching Methods 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 230000002829 reductive effect Effects 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 238000004062 sedimentation Methods 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 230000037394 skin elasticity Effects 0.000 description 2
- 235000013555 soy sauce Nutrition 0.000 description 2
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 2
- 231100000240 steatosis hepatitis Toxicity 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 230000002936 tranquilizing effect Effects 0.000 description 2
- -1 triterpene compound Chemical class 0.000 description 2
- 201000008297 typhoid fever Diseases 0.000 description 2
- BZFBDUQOBQHBSZ-DLCQERRASA-N (3s,8r,9s,10r,13s,14s,17s)-17-[3-(dimethylamino)propyl-methylamino]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1h-cyclopenta[a]phenanthren-3-ol;dihydrochloride Chemical compound Cl.Cl.C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](N(C)CCCN(C)C)[C@@]1(C)CC2 BZFBDUQOBQHBSZ-DLCQERRASA-N 0.000 description 1
- LOTKRQAVGJMPNV-UHFFFAOYSA-N 1-fluoro-2,4-dinitrobenzene Chemical compound [O-][N+](=O)C1=CC=C(F)C([N+]([O-])=O)=C1 LOTKRQAVGJMPNV-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- HIXDQWDOVZUNNA-UHFFFAOYSA-N 2-(3,4-dimethoxyphenyl)-5-hydroxy-7-methoxychromen-4-one Chemical compound C=1C(OC)=CC(O)=C(C(C=2)=O)C=1OC=2C1=CC=C(OC)C(OC)=C1 HIXDQWDOVZUNNA-UHFFFAOYSA-N 0.000 description 1
- MIDXCONKKJTLDX-UHFFFAOYSA-N 3,5-dimethylcyclopentane-1,2-dione Chemical compound CC1CC(C)C(=O)C1=O MIDXCONKKJTLDX-UHFFFAOYSA-N 0.000 description 1
- KKAJSJJFBSOMGS-UHFFFAOYSA-N 3,6-diamino-10-methylacridinium chloride Chemical compound [Cl-].C1=C(N)C=C2[N+](C)=C(C=C(N)C=C3)C3=CC2=C1 KKAJSJJFBSOMGS-UHFFFAOYSA-N 0.000 description 1
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 206010000077 Abdominal mass Diseases 0.000 description 1
- 206010002091 Anaesthesia Diseases 0.000 description 1
- 206010003694 Atrophy Diseases 0.000 description 1
- 241000304886 Bacilli Species 0.000 description 1
- KWIUHFFTVRNATP-UHFFFAOYSA-N Betaine Natural products C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 208000001378 Carbon Tetrachloride Poisoning Diseases 0.000 description 1
- 208000010445 Chilblains Diseases 0.000 description 1
- 206010008528 Chillblains Diseases 0.000 description 1
- 206010008909 Chronic Hepatitis Diseases 0.000 description 1
- 235000007516 Chrysanthemum Nutrition 0.000 description 1
- 244000189548 Chrysanthemum x morifolium Species 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 241000186227 Corynebacterium diphtheriae Species 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 206010012335 Dependence Diseases 0.000 description 1
- 206010013786 Dry skin Diseases 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- OTMSDBZUPAUEDD-UHFFFAOYSA-N Ethane Chemical compound CC OTMSDBZUPAUEDD-UHFFFAOYSA-N 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- 206010016654 Fibrosis Diseases 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 1
- 108010023302 HDL Cholesterol Proteins 0.000 description 1
- 108010006464 Hemolysin Proteins Proteins 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 206010019617 Henoch-Schonlein purpura Diseases 0.000 description 1
- 206010019909 Hernia Diseases 0.000 description 1
- 206010049077 Hernia pain Diseases 0.000 description 1
- 208000005100 Herpetic Keratitis Diseases 0.000 description 1
- 102000004286 Hydroxymethylglutaryl CoA Reductases Human genes 0.000 description 1
- 108090000895 Hydroxymethylglutaryl CoA Reductases Proteins 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 208000031814 IgA Vasculitis Diseases 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- UGNZSMZSJYOGNX-UHFFFAOYSA-N Isoviocristine Natural products O=C1C=C(C)C(=O)C2=CC3=CC(OC)=CC(O)=C3C(O)=C21 UGNZSMZSJYOGNX-UHFFFAOYSA-N 0.000 description 1
- 241000581650 Ivesia Species 0.000 description 1
- 108010028554 LDL Cholesterol Proteins 0.000 description 1
- 244000113306 Monascus purpureus Species 0.000 description 1
- 235000002322 Monascus purpureus Nutrition 0.000 description 1
- 241000031003 Monascus ruber Species 0.000 description 1
- 240000000249 Morus alba Species 0.000 description 1
- 235000008708 Morus alba Nutrition 0.000 description 1
- 206010028034 Mouth ulceration Diseases 0.000 description 1
- 102000016943 Muramidase Human genes 0.000 description 1
- 108010014251 Muramidase Proteins 0.000 description 1
- KWIUHFFTVRNATP-UHFFFAOYSA-O N,N,N-trimethylglycinium Chemical compound C[N+](C)(C)CC(O)=O KWIUHFFTVRNATP-UHFFFAOYSA-O 0.000 description 1
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 1
- UBUCNCOMADRQHX-UHFFFAOYSA-N N-Nitrosodiphenylamine Chemical compound C=1C=CC=CC=1N(N=O)C1=CC=CC=C1 UBUCNCOMADRQHX-UHFFFAOYSA-N 0.000 description 1
- 108010052989 Naphthol AS D Esterase Proteins 0.000 description 1
- 208000006595 Necrotizing Ulcerative Gingivitis Diseases 0.000 description 1
- 206010029164 Nephrotic syndrome Diseases 0.000 description 1
- CFLNHFUPWNRWJA-UHFFFAOYSA-N Obtusin Chemical compound O=C1C2=CC(C)=C(O)C(OC)=C2C(=O)C2=C1C=C(OC)C(OC)=C2O CFLNHFUPWNRWJA-UHFFFAOYSA-N 0.000 description 1
- OBBJQZSMXOJMCN-UHFFFAOYSA-N Obtusin Natural products COc1cc2C=CC(=O)Oc2c3OCC(Oc13)C(=C)C OBBJQZSMXOJMCN-UHFFFAOYSA-N 0.000 description 1
- 206010073938 Ophthalmic herpes simplex Diseases 0.000 description 1
- 244000170916 Paeonia officinalis Species 0.000 description 1
- 235000006484 Paeonia officinalis Nutrition 0.000 description 1
- 241000009328 Perro Species 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- XACHQDDXHDTRLX-GMPBGBGESA-N Physalien Natural products O=C(O[C@H]1CC(C)(C)C(/C=C/C(=C\C=C\C(=C/C=C/C=C(\C=C\C=C(/C=C/C=2C(C)(C)C[C@H](OC(=O)CCCCCCCCCCCCCCC)CC=2C)\C)/C)\C)/C)=C(C)C1)CCCCCCCCCCCCCCC XACHQDDXHDTRLX-GMPBGBGESA-N 0.000 description 1
- 206010067171 Regurgitation Diseases 0.000 description 1
- 208000034189 Sclerosis Diseases 0.000 description 1
- 229920005654 Sephadex Polymers 0.000 description 1
- 239000012507 Sephadex™ Substances 0.000 description 1
- 241000191940 Staphylococcus Species 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 208000009205 Tinnitus Diseases 0.000 description 1
- 206010047513 Vision blurred Diseases 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 206010048259 Zinc deficiency Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 238000005903 acid hydrolysis reaction Methods 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 210000000577 adipose tissue Anatomy 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- GZCGUPFRVQAUEE-SLPGGIOYSA-N aldehydo-D-glucose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O GZCGUPFRVQAUEE-SLPGGIOYSA-N 0.000 description 1
- 150000001335 aliphatic alkanes Chemical class 0.000 description 1
- 125000001931 aliphatic group Chemical group 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 230000037005 anaesthesia Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- WLXGUTUUWXVZNM-UHFFFAOYSA-N anthraglycoside A Natural products C1=C(C)C=C2C(=O)C3=CC(OC)=CC(O)=C3C(=O)C2=C1OC1OC(CO)C(O)C(O)C1O WLXGUTUUWXVZNM-UHFFFAOYSA-N 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000002929 anti-fatigue Effects 0.000 description 1
- 230000001857 anti-mycotic effect Effects 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 230000003356 anti-rheumatic effect Effects 0.000 description 1
- 230000002155 anti-virotic effect Effects 0.000 description 1
- 239000002543 antimycotic Substances 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 239000003435 antirheumatic agent Substances 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 206010003246 arthritis Diseases 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- 230000003143 atherosclerotic effect Effects 0.000 description 1
- 230000037444 atrophy Effects 0.000 description 1
- 235000015241 bacon Nutrition 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 229960003237 betaine Drugs 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 230000037182 bone density Effects 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 230000008195 breast development Effects 0.000 description 1
- 235000012970 cakes Nutrition 0.000 description 1
- 235000013736 caramel Nutrition 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 230000002612 cardiopulmonary effect Effects 0.000 description 1
- 239000000496 cardiotonic agent Substances 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- WIIZWVCIJKGZOK-RKDXNWHRSA-N chloramphenicol Chemical compound ClC(Cl)C(=O)N[C@H](CO)[C@H](O)C1=CC=C([N+]([O-])=O)C=C1 WIIZWVCIJKGZOK-RKDXNWHRSA-N 0.000 description 1
- 229960005091 chloramphenicol Drugs 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 230000007882 cirrhosis Effects 0.000 description 1
- 208000019425 cirrhosis of liver Diseases 0.000 description 1
- 239000007859 condensation product Substances 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- 229910001431 copper ion Inorganic materials 0.000 description 1
- 210000004351 coronary vessel Anatomy 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000013872 defecation Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 238000005238 degreasing Methods 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- MGRRGKWPEVFJSH-UHFFFAOYSA-N dianthrone Natural products C12=CC=CC=C2C(=O)C2=CC=CC=C2C1=C1C2=CC=CC=C2C(=O)C2=CC=CC=C21 MGRRGKWPEVFJSH-UHFFFAOYSA-N 0.000 description 1
- 235000007882 dietary composition Nutrition 0.000 description 1
- 238000003113 dilution method Methods 0.000 description 1
- XEYBRNLFEZDVAW-ARSRFYASSA-N dinoprostone Chemical compound CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1C\C=C/CCCC(O)=O XEYBRNLFEZDVAW-ARSRFYASSA-N 0.000 description 1
- 229960002986 dinoprostone Drugs 0.000 description 1
- IZEKFCXSFNUWAM-UHFFFAOYSA-N dipyridamole Chemical compound C=12N=C(N(CCO)CCO)N=C(N3CCCCC3)C2=NC(N(CCO)CCO)=NC=1N1CCCCC1 IZEKFCXSFNUWAM-UHFFFAOYSA-N 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 230000037336 dry skin Effects 0.000 description 1
- 238000004043 dyeing Methods 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 229940088598 enzyme Drugs 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 210000003617 erythrocyte membrane Anatomy 0.000 description 1
- 239000003797 essential amino acid Substances 0.000 description 1
- 235000020776 essential amino acid Nutrition 0.000 description 1
- RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 210000003608 fece Anatomy 0.000 description 1
- 229930003944 flavone Natural products 0.000 description 1
- 150000002212 flavone derivatives Chemical class 0.000 description 1
- 235000011949 flavones Nutrition 0.000 description 1
- 235000013373 food additive Nutrition 0.000 description 1
- 239000002778 food additive Substances 0.000 description 1
- 239000000576 food coloring agent Substances 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 235000015203 fruit juice Nutrition 0.000 description 1
- 108010074605 gamma-Globulins Proteins 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 210000004051 gastric juice Anatomy 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 229930182478 glucoside Natural products 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 210000003128 head Anatomy 0.000 description 1
- 239000003228 hemolysin Substances 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- 230000002443 hepatoprotective effect Effects 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 235000003642 hunger Nutrition 0.000 description 1
- 238000007654 immersion Methods 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 208000015446 immunoglobulin a vasculitis Diseases 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- GOMNOOKGLZYEJT-UHFFFAOYSA-N isoflavone Chemical compound C=1OC2=CC=CC=C2C(=O)C=1C1=CC=CC=C1 GOMNOOKGLZYEJT-UHFFFAOYSA-N 0.000 description 1
- 150000002515 isoflavone derivatives Chemical class 0.000 description 1
- 235000015094 jam Nutrition 0.000 description 1
- 210000000629 knee joint Anatomy 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 230000002475 laxative effect Effects 0.000 description 1
- 230000037356 lipid metabolism Effects 0.000 description 1
- 201000007270 liver cancer Diseases 0.000 description 1
- 210000005229 liver cell Anatomy 0.000 description 1
- 208000014018 liver neoplasm Diseases 0.000 description 1
- 239000002932 luster Substances 0.000 description 1
- 229960000274 lysozyme Drugs 0.000 description 1
- 239000004325 lysozyme Substances 0.000 description 1
- 235000010335 lysozyme Nutrition 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 235000013622 meat product Nutrition 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 229940057059 monascus purpureus Drugs 0.000 description 1
- 229940099908 multivitamin and calcium Drugs 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 230000003387 muscular Effects 0.000 description 1
- 208000031225 myocardial ischemia Diseases 0.000 description 1
- 230000018791 negative regulation of catalytic activity Effects 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- NYRXUBDGDSRBGB-UHFFFAOYSA-N obtusifoline Natural products O=C1C2=CC=CC(O)=C2C(=O)C2=C1C=C(C)C(O)=C2OC NYRXUBDGDSRBGB-UHFFFAOYSA-N 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000001151 other effect Effects 0.000 description 1
- 230000000242 pagocytic effect Effects 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 210000003024 peritoneal macrophage Anatomy 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 229930184989 physalin Natural products 0.000 description 1
- PKUBGLYEOAJPEG-UHFFFAOYSA-N physcion Natural products C1=C(C)C=C2C(=O)C3=CC(C)=CC(O)=C3C(=O)C2=C1O PKUBGLYEOAJPEG-UHFFFAOYSA-N 0.000 description 1
- 238000005554 pickling Methods 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- XEYBRNLFEZDVAW-UHFFFAOYSA-N prostaglandin E2 Natural products CCCCCC(O)C=CC1C(O)CC(=O)C1CC=CCCCC(O)=O XEYBRNLFEZDVAW-UHFFFAOYSA-N 0.000 description 1
- 150000003180 prostaglandins Chemical class 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 208000008128 pulmonary tuberculosis Diseases 0.000 description 1
- 210000001747 pupil Anatomy 0.000 description 1
- 230000000171 quenching effect Effects 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 235000020095 red wine Nutrition 0.000 description 1
- 230000002787 reinforcement Effects 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 235000015067 sauces Nutrition 0.000 description 1
- 230000009182 swimming Effects 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 210000001541 thymus gland Anatomy 0.000 description 1
- 231100000886 tinnitus Toxicity 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 1
- 230000007306 turnover Effects 0.000 description 1
- 201000008587 ulcerative stomatitis Diseases 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 235000021419 vinegar Nutrition 0.000 description 1
- 239000000052 vinegar Substances 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 1
- XACHQDDXHDTRLX-HZXCUAKRSA-N zeaxanthin dipalmitate Chemical compound CC1(C)CC(OC(=O)CCCCCCCCCCCCCCC)CC(C)=C1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CC(OC(=O)CCCCCCCCCCCCCCC)CC1(C)C XACHQDDXHDTRLX-HZXCUAKRSA-N 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/02—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation containing fruit or vegetable juices
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/52—Adding ingredients
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a formula of plant beverage in the field of food. The formula comprises the following components: 0-10% of white granulated sugar, 0.01-1% of red rice, 2-20% of Chinese date, 2-20% of hawthorn, 2-20% of semen cassiae, 2-20% of fructus lycii, 2-20% of rhizoma polygonati, 2-20% of Chinese yam and 2-20% of radix puerariae. The formula is prepared by dissolving the components in water, crushing, soaking, centrifuging, refined filtration, degassing, sterilization, encapsulation and the like. The technical key point is the components of the formula. At present, people are high in living standard and less in sport, and hyperlipidemia, hypertension, hyperglycemia, obesity and frequently excessive drinking people are increasing, so that the people need daily beverage capable of reducing hyperlipidemia, hypertension and hyperglycemia, losing weight, reinforcing, hairdressing, expelling toxin, protecting a liver, nourishing yin, supporting yang and improving calcium absorption for health of the people. For example, one of effects of the formula is to reduce blood fat, so that when the blood fat is low, heart and cerebral vessels are smooth, diseases such as cerebral infarction and myocardial infarction are delayed, and the people are healthy and long-life. Therefore, the formula contributes to health and long lives of countrymen.
Description
Technical field
The invention of this vegetable beverage prescription relates to field of food.Its formula consists of, white granulated sugar 0-10%, red colouring agent for food, also used as a Chinese medicine 0.01-1%, date 2-20%, hawthorn 2-20%, cassia seed 2-20%, fruit of Chinese wolfberry 2-20%, sealwort 2-20%, root of kudzu vine 2-20%, its in be water through particle, soak, centrifugal, essence filter, degassed, sterilization and the technique such as filling are made.
Background technology
Red colouring agent for food, also used as a Chinese medicine is taking long-grained nonglutinous rice as raw material, and the monascus ruber (monascuspurpureus) that adopts modern biotechnology to isolate high-quality forms through liquid deep layer fermenting exquisiteness, is a kind of pure natural, safe, the food additives that are of value to health.And this product lovely luster, tone is pure, full, photo and thermal stability is good, is the desirable colouring agent of natural green food.It has wide range of applications, and comprises foodstuff (meat products, fruit juice, color wine, jam, beverage, candy, cake, soy sauce, health-care vinegar etc.); Drug class (coloring medicine agent, functional health product); Toiletries red colouring agent for food, also used as a Chinese medicine is a kind of red mould, and the ancient Chinese people recognize its edibility very early.Red colouring agent for food, also used as a Chinese medicine purposes is extremely wide, as ancient times not the special dark reddish brown of invention soy sauce (caramel) before, red colouring agent for food, also used as a Chinese medicine is the main food coloring of pork braised in brown sauce and other red food.Red colouring agent for food, also used as a Chinese medicine or a kind of outstanding raw materials for food industry.Red rice wine (red wine) popularity on Southeast Asia and market, Hong Kong, Macao and Taiwan of utilizing red colouring agent for food, also used as a Chinese medicine to produce as Chinese Fujian platform two provinces is higher, quite gets consumer reception, and being acknowledged as relaxes the muscles and stimulate the blood circulation keeps fit effect.Yamato is affected by Chinese culture deeply, and they are also delithted with red colouring agent for food, also used as a Chinese medicine.As Japanese Rural in the time pickling pork with regard to addition red colouring agent for food, also used as a Chinese medicine, under the effect of monascus albumen phenol, bacon fine and tender taste, outward appearance is peony, makes us having a very good appetite.To the modern times, the research of red colouring agent for food, also used as a Chinese medicine has obtained the concern in the world.The biologist of Peking University filters out a strain Monascus from numerous Monascus kinds, has found to reduce the natural statin substance of serum cholesterol in its metabolite.Having passed through a large amount of work is production bacterial classification by wild-type strain variation, make it to produce high-load, human body synthetic cholesterol key enzyme (HMG---CoA reductase) the natural statin substance of specific inhibitor one stable, that be applicable to pharmacy, can also produce many compositions useful to human body, as aliphatic acid etc. is closed in essential amino acid, insatiable hunger simultaneously.At this moment red colouring agent for food, also used as a Chinese medicine with generally only make a big difference as the red colouring agent for food, also used as a Chinese medicine of pigment, be therefore called purpose-made monascus.Purpose-made monascus is now for pharmacy, large quantity research find it there is very powerful reduction T-CHOL, reduce LDL-C, reduce serum triglyceride, reduce the remarkable comprehensive therapeutic effect of AI, increasing high density lipoprotein cholesterol and take safe, side effect is little, and can effectively treat the cardiovascular and cerebrovascular disease such as coronary heart disease, headstroke and the disease relevant to high fat of blood, as diabetes, nephrotic syndrome and fatty liver.Be considered to the most promising current lipopenicillinase material.
The CAMP that red date is contained, is the essential composition of human body cell energetic supersession, can strengthen muscular strength, eliminates fatigue, hemangiectasis, increase myocardial contractive power, improve myocardial nutrition, has good effect to preventing and treating disease of cardiovascular system; Traditional Chinese medicine theory thinks, red date has the effects such as qi-restoratives benefit gas, nourishing blood and tranquilization, strengthening the spleen and stomach, and red date has good therapeutic effect to illnesss such as chronic hepatitis, cirrhosis, anaemia, anaphylactoid purpuras; Red date contains triterpene compound and CAMP, has stronger anticancer, anti-allergic effects.
datecan moisten cardiopulmonary, cough-relieving, tonifying five zang organs, control deficient, except stomach addiction gas, in can also pacifying, support spleen, flat stomach Qi, logical nine orifices, help 12 through etc.
Hawthorn: [function cures mainly] helps digestion long-pending, loose hemostasis, expelling tenia.Control meat long-pending, abdominal mass, phlegm and retained fluid, ruffian is full, and acid regurgitation rushes down dysentery, intestines wind, pain in the back, hernia postpartum abdominal pain in postpartum, lochiorrhagia, children's's breast food is stagnated.Food digesting stomach fortifying, the promoting the circulation of qi stasis of blood of faling apart.For carnivorous stagnant, stomach alkane turgor, rush down dysentery stomachache, hemostasis through closing, postpartum stasis blocking, trusted subordinate's shouting pain, hernia pain, hyperlipemia.Hawthorn has beauty treatment weight reducing, and woman's weight-reducing tablet hawthorn contains the substance such as vitamin C, carrotene blocks and reduce the generation of free radical, can strengthen the immunity of body, has anti-aging, anticancer effect; Women eats effect that hawthorn can be eliminated body fat, be reduced fat absorption more, can reach the effect of U.S. face weight reducing for the women who likes to be beautiful.Hawthorn has step-down, and lipopenicillinase is anti-oxidant, strengthens immunity, removes intestines and stomach harmful bacteria etc., also can prevent liver cancer.The male sex obtained fatty liver, will support protecting liver, supported protecting liver, first-elected hawthorn.Hawthorn, can be aid digestion, has nourishing the liver degrease effect.Hawthorn can significantly reduce serum cholesterol and triglycerides, effectively prevents and treats atherosclerotic; Hawthorn can also play cardiac stimulant and prevent anginal effect by strengthening myocardial contractive power, increase cardiac output, coronary artery dilator blood vessel, increase CF, reduction MCO etc.In addition, the general flavone in hawthorn has the effect of hemangiectasis and lasting step-down.Hawthorn has the effect activating blood circulation and dispersing blood clots, and is blood stasis type dysmenorrhoea patient's dietotherapy good merchantable brand.Blood stasis type dysmenorrhoea patient often shows as and passes through 1st～2 days or underbelly pain occurs for premenstrual 1～2 day, and in the time that menses are discharged smoothness, pain alleviates gradually or disappears, and menses darker in color, with clot.
Cassia seed claims again " going back pupil ", and cassia seed contains multivitamin and abundant amino acid, fat, carbohydrate etc., and its health care is subject to people's attention day by day.Cassia seed has the functions such as clearing away the liver-fire, wines used as antirheumatic, tonifying kidney and improving eyesight, often drinks cassia-tora tea, can make blood pressure normal, free movement of the bowels, and old eye is not spent.Clinical trial certificate, drinks cassia-tora tea and can clear liver and improve vision, prevent eye-blurred, hypotensive, reducing blood lipid, minimizing cholesterol etc., for preventing and treating coronary heart disease, hypertension has good curative effect; And cassia seed is rich in vitamin A and zinc, can prevents and treats yctalopia and avoid zinc deficiency in children.In addition, the function that cassia-tora tea relaxes bowel also can solve the problem of modern's stomach and constipation, can treat dry feces, helps smooth defecation.The bubble method of cassia-tora tea is very simple, as long as brew with the hot boiling water of 15～20 grams of cassia seeds, also can put into appropriate sugar according to personal like, when tea-drinking use, every day several, if can mix the fruit of Chinese wolfberry and chrysanthemum, effect is better.But, cassia seed cold nature, the people of easily diarrhoea, diarrhoea, stomachache, should not drink this tea.1. antibacterial action: cassia seed alcohol extract all has inhibitory action to staphylococcus, corynebacterium diphtheriae, typhoid bacillus, paratyphosum Bacterium, Escherichia coli, water extract is invalid.2. antimycotic: water logging agent tube dilution method, 1
:20 pairs of microsporon audouinis, 1
:permitted blue achorion and Microsporum gypseum all has inhibitory action for 10 pairs.3. step-down: water logging agent and ethanol immersion liquid all have hypotensive effect to anesthesia dog, cat, rabbit.4. reducing blood lipid: cassia seed decoction or Trial On The Action of Semen Cassiae Powder 6g/ only feed and raise rat 8 weeks, can reduce blood plasma ornitrol, triglycerides, and reduce the content of triglycerides in liver to Experimental Hyperlipemia disease rat.5. platelet aggregation-against: cassia seed decoction or powder 6g/kg feed and raise rat 8 weeks, has inhibitory action to the rat platelet aggregation of ADP induction.6. affecting cassia seed water decoction-alcohol sedimentation agent 15g/kg hypodermic injection and can make mouse thymus atrophy immunologic function, PBLC ANAE dyeing negative rate obviously reduces, make 2,4-dinitrofluorobenzene (DNCB) induced mice skin delayed allergy is suppressed, but serum hemolysin is formed and had no significant effect, the agent of cassia seed water decoction-alcohol sedimentation can make Turnover of Mouse Peritoneal Macrophages engulf chicken red blood cell percentage in addition and phagocytic index obviously increases, and Lysozyme Levels is also apparently higher than control group.7. the oral 670mg/kg of hepatoprotective effect cassia seed hot water extract has weak detoxication to carbon tetrachloride poisoning mouse liver.Cassia seed is through petroleum ether degreasing, chloroform recovery, then extracts with methyl alcohol, and this methanolic extract of result has significant liver protection effect.Further therefrom get Chrysophanol-l-O-tri-glucose glucoside, Chrysophanol-1-O-tetra-glycosides has weak protective effect to the liver cell of carbon tetrachloride-injured in the time of 1mg/ml, also finds that aloe-emodin also has similar anti-liver toxicity.8. discharge function cassia seed has laxative action.The oral rear discharge function of its liquid extract peaks at 3-5h.From decocting liquid, obtain 50% ethanol soluble fraction, use successively ethyl acetate, butyric acid, obtain respectively each soluble fraction and water-soluble part.Butanols part the highest Purgative activity is isolated to several components with sephadex column, by activated tool component acid hydrolysis, obtain identical Chrysophanol, dianthrone and d-glucose.After oral these components, can in large intestine, condensation product and the chrysophanic acid anthrone of nitrosodiphenylamine be detected, but suppress the mouse of intestinal bacterium propagation to processing with chloramphenicol, its Purgative activity reduces by half, and anthrone generates also and reduces.9. on the impact of gastric secretion on an empty stomach edible cassia seed can promote the secretion of gastric juice.10. suppressing PGE2 that 15-hydroxy-prostaglandin dehydrogenase (15-OH PGDH) effect has a diuresis, to be through 15-hydroxy-prostaglandin dehydrogenase role transformation that 15-ketone is discharged to for prostaglandin external, can make diuresis extend by suppressing reaction in this body.Cassia seed aqueous extract has the 15-OH of inhibition PGDH activity.Extract successively with ethane, chloroform, methyl alcohol, water, analyse method with post again and separate inhibition of enzyme activity material, the IC50 that finds anthraquinone derivative obtusin and obtusifoline is respectively 1.064 × 10mol/, 1.666 × 10mol/L, the anthraquinone derivative Chrysophanol coexisting and the IC50 of Physcion are respectively 1.789 × 10mol/L, 1.236 × 10mol/L, suppress active all samples all a little less than.
The fruit of Chinese wolfberry: cure mainly nourishing liver and kidney, benefiting shrewd head.Lose for consumptive disease essence, soreness of waist and knee joint, dizzy tinnitus, interior heat is quenched one's thirst, and the deficiency of blood is sallow, and blurred vision is not clear.In the fruit of Chinese wolfberry, contain 14 seed amino acids, and contain the special dietary compositions such as betaine, beautiful another name for Sichuan Province flavine, physalin, make it have outstanding health-care efficacy.Draw the essential nutriment that the fruit of Chinese wolfberry contains the healthy eye such as abundant carrotene, multivitamin and calcium, iron, therefore there is the merit of improving eyesight, be commonly called as " bright eye ".What ancient Chinese medicine doctor treatment deficiency of liver-blood, deficiency of kidney-YIN caused looks thing duskization and yctalopia, usually uses the fruit of Chinese wolfberry.
sealwort: pharmacological action
1, resisting pathogenic microbes effect: in vitro test shows, sealwort water extraction fluid (1:320) has inhibitory action to typhoid bacillus, staphylococcus aureus, acid-fast bacilli, and 2% sealwort has inhibitory action in various degree to common pathomycete in sabouraud culture medium.2, the impact on blood sugar: rabbit gavage sealwort medicinal extract, its blood-sugar content increases gradually, then reduces.The too high inhibitory action that manifesting of blood sugar that sealwort medicinal extract causes adrenaline.3, antifatigue effect: a sealwort decoction 17.67% concentration 0.3ml/ lumbar injection, can extend mouse swimming time.4, antioxidation: sealwort decocting liquid 20% concentration, 13ml/ only feeds drink, and continuous 27 days, make the active rising of mouse liver superoxide dismutase (SOD), myocardium lipofuscin content reduces.5, delaying senility function: sealwort decoction, 20% concentration is soaked mulberry leaf and fed silkworm, has the effect that extends the silkworm larva phase.6, anastalsis: sealwort methanolic extract 40mg/ only, n-butanol part 20mg/ only, water layer part 20mg/ only, lumbar injection, to the freezing mouse tail of dry ice-methyl alcohol 1 minute, the experiment of back-end crop method showed there is anastalsis, and mouse amount of bleeding is reduced.7, to Cardiovascular: sealwort aqueous extract 0.16 ~ 0.26g/kg intravenous injection, obviously increases anesthetized dog coronary flow; 1.5g/kg intravenous injection, the rabbit myocardial ischemia that pituitrin is caused has antagonism, and the T ripple that antagonism pituitrin causes increases, and promotes T ripple to recover extremely in advance; 12g/kg lumbar injection, can strengthen the tolerance of mouse to anoxic.8, antivirus action: 0.2% drop eye of Siberian solomonseal rhizome polysaccharide, 6 times/day, or add Siberian solomonseal rhizome polysaccharide 10mg/kg, 2 times/day, the experimental herpes simplex keratitis of rabbit is all had to therapeutic action.9, other effect: sealwort decoction 6g/kg gavage, continuous 10 days, can improve Movse Erythrocyte Membrane Na+, K+--atpase activity.40% 0.3ml/ of sealwort alcohol extract lumbar injection, can improve mouse cardiac muscle, liver, the incorporation efficiency of spleen histocyte DNA to 3H ~ TdR.0.5g/ gavage of sealwort decoction makes mice plasma cAMP, and cGMP content all declines, and it is more to decline with cGMP, and therefore cAMP/cGMP ratio is greater than control group, and spleen is organized to cAMP, and cGMP content all rises, but cAMP/cGMP ratio is without significant change.
Chinese yam " book on Chinese herbal medicine is looked for the truth ": " enter in drugs for nourishing yin and should give birth to use, entering tonifying spleen lung medicine should use by stir-bake to yellowish." " this genus food, though gas is warm and flat, is the moon of tonifying spleen lung.Can moisten fur, longue meat, taste is sweet double salty, again can kidney-nourishing reinforcing yin essence.”
In the research of C-II induced arthritis in rats, Chinese yam water extraction liquid can significantly suppress the denaturation of Cu2+to gamma Globulin, shows to have antarthritic effect.Chinese yam water extraction liquid also can be eliminated urine albumen, mutant cell is had to the effect that suppresses generation.
1, tonifying middle-Jiao and Qi: iron rod yam is planted trace element because being rich in 18 seed amino acids and more than 10, and other mineral matter, so have strengthening the spleen and stomach, tonifying lung kidney, tonifying middle-Jiao and Qi, invigorating the spleen qi-restoratives, the effects such as beneficial essence, beneficial heart and tranquilizing mind of reinforcing the kidney, in Li Shizhen (1518-1593 A.D.) Compendium of Material Medica, there is saying of " all kinds of diseases and ailments are reinforced the kidney, controlled to invigorating the spleen help, taste essence, treats general debility ".
2, quench one's thirst and promote the production of body fluid: this Chinese yam has effect of the life of quenching one's thirst: Chinese traditional treatment consumptive disease is quenched one's thirst in (diabetes) prescription often has Chinese yam single to use, or share with other medicines, and effect is better.
3, health care: because fresh Chinese yam is rich in multivitamin, amino acid and mineral matter, can prevent and treat Human Lipid Metabolism abnormal, and artery sclerosis, to safeguarding that insulin normal function also has certain effect, there is enhancing body immunity, beneficial heart and tranquilizing mind, rather cough Dingchuan, the health-care effect such as delay senility.
4, beauty treatment: Yuan Dynasty taste expert Li Gao says: " control dry skin and moisten it with this thing." Li Shizhen (1518-1593 A.D.) is write: " Chinese yam can be moistened fur." Chinese yam is to nourishes rough skin, and vigorous and graceful beauty treatment has unique curative effect.
5, iron rod yam special pharmacological function: the copper ion in Chinese yam and connective tissue have very big help to human development, vascular system disease is had to obvious curative effects, calcium in iron rod yam, the injury of the tissues is damaged to bone, osteoporosis, loss of tooth has high curative effect, pernio, diabetes, hepatitis, children's's diarrhea, enruesis, baby's indigestion, ulcerative stomatitis, pulmonary tuberculosis, the inferior patient of woman month band are also had to good curative effect, with can be clear-headed and clear-sighted, promote longevity for a long time.
The root of kudzu vine has the effects such as the body of taste is healthy and strong, anti-ageing, step-down, hypoglycemic, lipopenicillinase, increase skin elasticity, moisturizing.In the root of kudzu vine, institute's isoflavone-containing has skin care, recovers the effect of skin elasticity, can also slow down the aging of skeletal tissue's cell, contributes to calcareous absorption, reduces bone calcium and loses, increase bone density and stop the hollow of bone to disappear molten, thereby away from osteoporosis.Active component in the root of kudzu vine can prevent cardio-cerebrovascular diseases and effectively alleviate climacteric metancholia, and can promote longevity again, improve health, be female middle-aged daily health caring, the ideal chose of improving the quality of living.The most recommendable, women often eats the root of kudzu vine, can impel breast development to increase, and this is exactly mainly the contribution of isoflavones.
Summary of the invention
The present invention is a kind of formula of field of food beverage, and its formula consists of.White granulated sugar 0-10%, red colouring agent for food, also used as a Chinese medicine 0.01-1%, date 2-20%, hawthorn 2-20%, cassia seed 2-20%, fruit of Chinese wolfberry 2-20%, sealwort 2-20%, Chinese yam 2-20%, root of kudzu vine 2-20%, it is in being water.Through particle, soak, centrifugal, essence filter, degassed, sterilization and the technique such as filling are made.There is reducing blood lipid, hypotensive, hypoglycemic, fat-reducing, reinforcement, beauty treatment, toxin expelling, maintenance liver, Yin-nourishing and Yang-supporting, strengthens the daily drink of the functions such as calcareous absorption.
Claims (1)
1. the present invention is a kind of formula of field of food beverage, and its claim is the composition of formula, and its formula consists of, white granulated sugar 0-10%, red colouring agent for food, also used as a Chinese medicine 0.01-1%, date 2-20%, hawthorn 2-20%, cassia seed 2-20%, fruit of Chinese wolfberry 2-20%, sealwort 2-20%, Chinese yam 220%, root of kudzu vine 2-20%, it is in being water, through particle, soak, centrifugal, essence filter, degassed, the plant beverage that sterilization and the technique such as filling are made.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410486537.3A CN104188036A (en) | 2014-09-23 | 2014-09-23 | Formula of plant beverage |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410486537.3A CN104188036A (en) | 2014-09-23 | 2014-09-23 | Formula of plant beverage |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN104188036A true CN104188036A (en) | 2014-12-10 |
Family
ID=52073551
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201410486537.3A Pending CN104188036A (en) | 2014-09-23 | 2014-09-23 | Formula of plant beverage |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104188036A (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104489200A (en) * | 2014-12-31 | 2015-04-08 | 西安德立生物化工有限公司 | Health and beauty-maintaining tea for middle aged and elderly people and preparation method of health and beauty-maintaining tea |
| CN104738783A (en) * | 2015-04-28 | 2015-07-01 | 王善广 | Chinese medicinal beverage for relieving sequel of cerebral infarction and preparation method |
-
2014
- 2014-09-23 CN CN201410486537.3A patent/CN104188036A/en active Pending
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104489200A (en) * | 2014-12-31 | 2015-04-08 | 西安德立生物化工有限公司 | Health and beauty-maintaining tea for middle aged and elderly people and preparation method of health and beauty-maintaining tea |
| CN104738783A (en) * | 2015-04-28 | 2015-07-01 | 王善广 | Chinese medicinal beverage for relieving sequel of cerebral infarction and preparation method |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102115707B (en) | Health wine and preparation process thereof | |
| CN104856003A (en) | Non-full nutritional formula food for patients with diabetes | |
| CN102948563A (en) | Traditional Chinese medicine diet health tea | |
| CN103859378A (en) | Formula and preparation method of life cultivation and health preservation food helpful for reducing blood sugar | |
| CN101238893B (en) | High edible fibre chickpea nutritive powder and preparation and application thereof | |
| CN106562413A (en) | Oral thick paste for immunity enhancement and preparation method thereof | |
| CN105079465A (en) | Composition capable of lowering blood glucose | |
| CN103859375A (en) | Formula and preparation method of life cultivation and health preservation food helpful for enhancing immunity | |
| CN102204610B (en) | Gingko health-care tea | |
| CN1275551C (en) | Green healthy beverage | |
| CN104906361A (en) | Hypolipidemic yellow rice wine and making method thereof | |
| CN108991078A (en) | A kind of mulberry leaf food of prevention and control rich people's disease and preparation method thereof | |
| CN104207241B (en) | A kind of integration of drinking and medicinal herbs composite health care beverage and preparation method thereof | |
| CN101185463A (en) | Fat-reducing health care breakfast milk | |
| CN104248013A (en) | Plant drink formula | |
| CN102511876B (en) | Hawthorn red jujube thick syrup and production process thereof | |
| CN104188036A (en) | Formula of plant beverage | |
| CN103798434A (en) | Health care tea bag as well as preparation method thereof | |
| CN104287008A (en) | Formula of plant drink | |
| CN102133283B (en) | Medicine for treating constipation and preparation method thereof | |
| CN100382832C (en) | Health foods in use for improving symptom in climacteric period of female and fabricating method | |
| CN1044965C (en) | Sand pear beverage | |
| CN103340991B (en) | Oral liquid for nursing diabetics and preparation method thereof | |
| CN102138593A (en) | Formula of lotus leaf fat eliminating and body building tea | |
| CN106720829A (en) | A kind of polygonatum Solomon's seal sugar-tablet and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| WD01 | Invention patent application deemed withdrawn after publication | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20141210 |